Zeillinger R - Search Results

1

Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice.

Leroy B, Ballinger ML, Baran-Marszak F, Bond GL, Braithwaite A, Concin N, Donehower LA, El-Deiry WS, Fenaux P, Gaidano G, Langerød A, Hellstrom-Lindberg E, Iggo R, Lehmann-Che J, Mai PL, Malkin D, Moll UM, Myers JN, Nichols KE, Pospisilova S, Ashton-Prolla P, Rossi D, Savage SA, Strong LC, Tonin PN, Zeillinger R, Zenz T, Fraumeni JF Jr, Taschner PE, Hainaut P, Soussi T. Leroy B, et al. Among authors: zeillinger r. Cancer Res. 2017 Mar 15;77(6):1250-1260. doi: 10.1158/0008-5472.CAN-16-2179. Cancer Res. 2017. PMID: 28254861 Free PMC article. Review.

2

Increased natural killer cell activity correlates with low or negative expression of the HER-2/neu oncogene in patients with breast cancer.

Wiltschke C, Tyl E, Speiser P, Steininger A, Zeillinger R, Kury F, Czerwenka K, Kubista E, Preis P, Krainer M, et al. Wiltschke C, et al. Among authors: zeillinger r. Cancer. 1994 Jan 1;73(1):135-9. doi: 10.1002/1097-0142(19940101)73:1<135::aid-cncr2820730123>3.0.co;2-s. Cancer. 1994. PMID: 7903907

3

A constitutional de novo mutation in exon 8 of the p53 gene in a patient with multiple primary malignancies.

Speiser P, Gharehbaghi-Schnell E, Eder S, Haid A, Kovarík J, Nenutil R, Sauter G, Schneeberger CH, Vojtesek B, Wiltschke CH, Zeillinger R. Speiser P, et al. Among authors: zeillinger r. Br J Cancer. 1996 Jul;74(2):269-73. doi: 10.1038/bjc.1996.350. Br J Cancer. 1996. PMID: 8688334 Free PMC article.

4

Association of allelic losses on human chromosomal arms 11Q and 16Q in sporadic breast cancer.

Schmutzler RK, Fimmers R, Bierhoff E, Lohmar B, Homann A, Speiser P, Kubista E, Jaeger K, Krebs D, Zeillinger R, Wiestler OD, Von Deimling A. Schmutzler RK, et al. Among authors: zeillinger r. Int J Cancer. 1996 Aug 22;69(4):307-11. doi: 10.1002/(SICI)1097-0215(19960822)69:4<307::AID-IJC12>3.0.CO;2-2. Int J Cancer. 1996. PMID: 8797873 Free article.

5

Genomic deletions in the BRCA1, BRCA2 and TP53 regions associate with low expression of the estrogen receptor in sporadic breast carcinoma.

Schmutzler RK, Bierhoff E, Werkhausen T, Fimmers R, Speiser P, Kubista E, Krebs D, Zeillinger R, Wiestler OD, Von Deimling A. Schmutzler RK, et al. Among authors: zeillinger r. Int J Cancer. 1997 Jun 20;74(3):322-5. doi: 10.1002/(sici)1097-0215(19970620)74:3<322::aid-ijc15>3.0.co;2-d. Int J Cancer. 1997. PMID: 9221812 Free article.

6

Messenger RNA determination of estrogen receptor, progesterone receptor, pS2, and plasminogen activator inhibitor-1 by competitive reverse transcription-polymerase chain reaction in human breast cancer.

Tong D, Schneeberger C, Czerwenka K, Schmutzler RK, Speiser P, Kucera E, Concin N, Kubista E, Leodolter S, Zeillinger R. Tong D, et al. Among authors: zeillinger r. Clin Cancer Res. 1999 Jun;5(6):1497-502. Clin Cancer Res. 1999. PMID: 10389938

7

P53 antibody response in patients with vulvar cancer.

Mayerhofer K, Hefler L, Schindl M, Concin N, Frischmuth K, Leodolter S, Zeillinger R, Reinthaller A, Kainz C. Mayerhofer K, et al. Among authors: zeillinger r. Anticancer Res. 1999 May-Jun;19(3B):2323-6. Anticancer Res. 1999. PMID: 10472352

8

Association of in vitro invasiveness and gene expression of estrogen receptor, progesterone receptor, pS2 and plasminogen activator inhibitor-1 in human breast cancer cell lines.

Tong D, Czerwenka K, Sedlak J, Schneeberger C, Schiebel I, Concin N, Leodolter S, Zeillinger R. Tong D, et al. Among authors: zeillinger r. Breast Cancer Res Treat. 1999 Jul;56(1):91-7. doi: 10.1023/a:1006262501062. Breast Cancer Res Treat. 1999. PMID: 10517346

9

p53-dependent radioresistance in ovarian carcinoma cell lines.

Concin N, Zeillinger C, Stimpfel M, Schiebel I, Tong D, Wolff U, Reiner A, Leodolter S, Zeillinger R. Concin N, et al. Among authors: zeillinger c, zeillinger r. Cancer Lett. 2000 Mar 31;150(2):191-9. doi: 10.1016/s0304-3835(99)00393-6. Cancer Lett. 2000. PMID: 10704742

10

Human progesterone receptor gene polymorphism PROGINS and risk for breast cancer in Austrian women.

Fabjani G, Tong D, Czerwenka K, Schuster E, Speiser P, Leodolter S, Zeillinger R. Fabjani G, et al. Among authors: zeillinger r. Breast Cancer Res Treat. 2002 Mar;72(2):131-7. doi: 10.1023/a:1014813931765. Breast Cancer Res Treat. 2002. PMID: 12038703

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

276 results

Search Page